Sustained Improvement of Cystic Fibrosis Lung Disease Following Initiation of Elexacaftor/Tezacaftor/Ivacaftor Therapy: Lessons from Real-World Studies.

Published in: American journal of respiratory and critical care medicine (2023)

Keyphrases